These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 36938794)
1. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations. Mangaonkar AA; Patnaik MM Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794 [TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis: Origins and determinants of evolution. Mendez LM; Patnaik MM Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557 [TBL] [Abstract][Full Text] [Related]
3. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation. Goldman EA; Spellman PT; Agarwal A Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927 [TBL] [Abstract][Full Text] [Related]
4. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies. Ye B; Sheng Y; Zhang M; Hu Y; Huang H Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959 [TBL] [Abstract][Full Text] [Related]
5. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic]. Ziemann F; Metzeler KH Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116 [TBL] [Abstract][Full Text] [Related]
6. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities. Younes IE; Syler L; Hamed A Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988 [TBL] [Abstract][Full Text] [Related]
7. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826 [TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us? Todisco G; Moura PL; Hellström-Lindberg E Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692 [TBL] [Abstract][Full Text] [Related]
9. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms. Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538 [TBL] [Abstract][Full Text] [Related]
11. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)? Steensma DP Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699 [TBL] [Abstract][Full Text] [Related]
12. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections. Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225 [TBL] [Abstract][Full Text] [Related]
13. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms. Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768 [TBL] [Abstract][Full Text] [Related]